Finance

Lists
Why is ANVS down 5,39%?
Dive Deeper
ANVS:NYSE
Annovis Bio Inc
0,99 $
-5,39%
(-0,057) 1D
0,99 $
0,00% (0,00)
After hours
Closed: 16 հոկ, 16:00:06 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANVS...
Open
1,06 $
High
1,08 $
Low
0,99 $
Mkt. cap
42,40 մլն
Avg. vol.
1,21 մլն
Volume
641,42 հզր
52-wk high
5,50 $
52-wk low
0,99 $
EPS
-1,78 $
Beta
1,23
Shares outstanding
42,68 մլն
No. of employees
8
Open
1,06 $
High
1,08 $
Low
0,99 $
Mkt. cap
42,40 մլն
Avg. vol.
1,21 մլն
Volume
641,42 հզր
52-wk high
5,50 $
52-wk low
0,99 $
EPS
-1,78 $
Beta
1,23
Shares outstanding
42,68 մլն
No. of employees
8
News stories
From web sources and news partners
About Annovis Bio Inc
CEOMaria-luisa Maccecchini
Employees8
Founded2008
HeadquartersMalvern, Փենսիլվանիա, Միացյալ Նահանգներ
Sector-
Websiteannovisbio.com
Analyst ratings
Based on 3 analysts giving stock ratings to ANVS in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ANVS in the last 3 months.
Highest
Current 0,99 $
17,00 $ (+1 611,29%)
Average
10,67 $ (+974,09%)
Lowest
7,00 $ (+604,65%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
7,00 $
+604,7%
09/04/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
17,00 $
+1 611,3%
08/18/2026
Jason McCarthy
Maxim Group
Buy
Maintained
8,00 $
+705,3%
08/17/2026
Unknown Analyst
Roth MKM
Buy
Initiated
8,00 $
+705,3%
07/07/2026
Last report
14 օգս, 2026 թ.
Fiscal period
Q2 2026
-0,40 $ / -0,46 $
+13,04%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6,29 մլն
8,75 մլն
16,72 մլն
12,01 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,14 մլն
955,15 հզր
1,19 մլն
2,37 մլն
Operating expense
7,43 մլն
9,71 մլն
17,91 մլն
14,38 մլն
Total operating expenses
7,43 մլն
9,71 մլն
17,91 մլն
14,38 մլն
Operating income
-7,43 մլն
-9,71 մլն
-17,91 մլն
-14,38 մլն
Other non operating income
20,00 հզր
-296,00 հզր
268,00 հզր
-603,34 հզր
EBT including unusual items
-7,26 մլն
-9,83 մլն
-17,61 մլն
-14,82 մլն
EBT excluding unusual items
-7,26 մլն
-9,83 մլն
-17,51 մլն
-14,82 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7,26 մլն
-9,83 մլն
-17,61 մլն
-14,82 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,37
-0,39
-0,63
-0,40
Interest and investment income
152,32 հզր
167,74 հզր
137,80 հզր
160,23 հզր
Interest expense
-
-
-
-
Net interest expenses
152,32 հզր
167,74 հզր
137,80 հզր
160,23 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps